Sixteen-year-old Austin Jin has developed a novel CRISPR-based blood test designed to detect tuberculosis (TB). For this technological innovation, Jin was awarded a prize of $50,000.
The development represents a significant application of CRISPR gene-editing technology for medical diagnostics, specifically targeting a major global health challenge in tuberculosis detection.
In-depth summary · AI, neutral